In the subgroup of stable IPF patients, IL-33 EBC follow-up levels (1.47 (1.41–1.66) pg/mL) did not differ significantly from baseline levels (1.47 (1.35–1.90) pg/mL). The gene discussed is IL33; the disease is idiopathic pulmonary fibrosis.